Equity

Merck & Co.·Balance Sheet Statement·15 metrics

Breakdown

Loading...

Metrics

Accumulated other comprehensive income (loss)

Shares Outstanding

Convertible Preferred Stock Authorized Shares

Cumulative Gross Losses and Impairments

Additional paid-in capital

Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

Number of Exercisable Options

Number of Vested and Expected to Vest Options

Retained earnings

Shares Reserved for Future Issuance Under Stock Plans

Total liabilities and stockholders' equity

Total stockholders' equity

Treasury stock

Weighted Average Exercise Price of Outstanding Options

Weighted Average Exercise Price of Vested and Expected to Vest Options